C12N2750/14332 - CPC Classification Index

ClassID:

110581 ⎘

C12N2750/14332 - CPC Classification

Classification description:

ssDNA viruses; Details; Parvoviridae; Parvovirus, e.g. minute virus of mice Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Recent Application in this class:

20250262296

2025-08-21

MODIFIED ONCOLYTIC PARVOVIRUS H-1PV WITH AN ENHANCED FITNESS AND SUPERIOR ANTICANCER ACTIVITY

20220265741

2022-08-25

Novel oncolytic parvoviruses with enhanced cargo capacity, stable shRNA expression cassette and novel immunogenic properties

20210228714

2021-07-29

Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

20210060102

2021-03-04

CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB

20190218523

2019-07-18

REMOVAL OF CONTAMINATING VIRUSES FROM AAV PREPARATIONS

20190117768

2019-04-25

Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

20180117104

2018-05-03

Cancer therapy with a parvovirus combined with a BCL-2 inhibitor

20180100143

2018-04-12

Removal of contaminating viruses from AAV preparations

20180028583

2018-02-01

Cancer therapy with a parvovirus combined with bevacizumab

#10

20170360858

2017-12-21

Transluminal delivery of viruses for treatment of diseased tissue

#11

20170266244

2017-09-21

Use of parvovirus for eliminating cancer stem cells (CSCs)

#12

20160082056

2016-03-24

Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor

#13

20150030567

2015-01-29

Cancer therapy with a parvovirus combined with an HDAC inhibitor

#14

20140342434

2014-11-20

Removal of contaminating viruses from AAV preparations

#15

20140235699

2014-08-21

Adeno-parvovirus chimera with enhanced oncolytical potential

#16

20140205573

2014-07-24

Oncolytic virotherapy for the therapy of ewing'S sarcoma

#17

20130344034

2013-12-26

Parovirus having a CpG-enriched genome useful for cancer therapy

#18

20130224154

2013-08-29

Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid

#19

20130209413

2013-08-15

Use of parvovirus for eliminating cancer stem cells (CSCs)

#20

20130189265

2013-07-25

Modified parvovirus having enhanced anti-tumor efficacy

#21

20130129683

2013-05-23

Modified rodent parvovirus capable of propagating and spreading through human gliomas

#22

20130058899

2013-03-07

Cancer Therapy with a Parvovirus Combined with an HDAC Inhibitor

#23

20130045235

2013-02-21

Autologous biological cancer vaccine

#24

20120237483

2012-09-20

Oncolytic virotherapy for prevention of tumor recurrence

#25

20120213734

2012-08-23

Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma

#26

20120201848

2012-08-09

Isolation of a virus related to canine parvovirus-2 from a raccoon

#27

20110033425

2011-02-10

Parvovirus having a CPG-enriched genome useful for cancer therapy

#28

20100331815

2010-12-30

Transluminal delivery of oncoltyic viruses for cancer therapy